Hypersensitivity to any of the components of Nervite.
Long-term use of large doses of Nervite6 may lead to severe peripheral neuropathies.
Tab Prevention or treatment of Nervite1, B6 & B12 deficiencies. Forte tab Neuralgia, neuritis, diabetic neuropathy, sciatica, Nervite deficiency, trigeminal neuralgia, intercostal neuralgia, hyperemesis gravidarum.
Nervite contains specific active ingredients such as carnitine orotate and hepatic extract antitoxic fraction.
Each vial contains: Carnitine orotate 300 mg (equivalent to carnitine 152.4 mg and orotic acid 147.6 mg), carnitine HCl 184 mg (equivalent to carnitine base 150 mg), hepatic (liver) extract antitoxic fraction 25 mg (equivalent to cyanocobalamin 0.25 mcg), pyridoxine HCl (vitamin B6) 25 mg, adenosine 5 mg, cyanocobalamin (vitamin B12) 250 mcg.
Sometimes, there is color disproportion by physical properties during freeze-drying process but therapeutic effect is not affected.
Inject 2 vials/day through IV instillation after dissolving each vial of the freeze-dried cake with 4 mL water for injection.
Administration: Nervite can be administered by LVP instillation process by diluting the solution to LVP solution. When using the LVP solution as diluent for Nervite injection, it has to be cautioned that the LVP solution must be non-electrolyte LVP (eg, 5% dextrose solution). If the electrolyte-containing LVP solution (eg, Ringer's solution) is used, carnitine orotate will precipitate in the solution.
It is recommended that in the administration method, diluted LVP solution must be used because direct instillation without dilution can induce serious pain in the injection site.
As much as possible, inject slowly because blood vessel pain may occur during IV injection.
High doses of Nervite6 may decrease the actions of L-dopa.
